Operating Partners
Shore operating partners bridge the financial expertise of Shore investment professionals with the operating and strategic needs of our portfolio companies. With more than 240 years of healthcare experience, Shore operating partners facilitate the implementation of value creation strategies through past experience and a deep network of industry relationships.
Bob DeCresce, MD, ClearPath Diagnostics Board of Directors Member
Dr. Bob DeCresce currently serves on the ClearPath Diagnostics Board of Directors. Bob has been Director of Clinical Laboratories at Rush University Medical Center since 1991 and serves as Chairman of the Department of Pathology at Rush Medical College in Chicago. He is also a member of the Board of Solstas Lab Partner, a diagnostic lab backed by the private equity firm, Welsh Carson Anderson & Stowe. In addition to serving on multiple lab company boards, Bob is a Director for VWR a worldwide distributor of scientific equipment and supplies with $4 billion in global sales.
From 1983 till 1987, Bob served as Vice President of MetPath, Inc., a division of Corning, Inc., and a predecessor to Quest Diagnostics. He was also previously on the Board of PathLab, Inc., a Madison Dearborn Portfolio Company sold to LabCorp in 2001 in a $110 million transaction.
Dr. DeCresce has a Bachelor of Science degree from Boston College, an MD from Columbia University College of Physicians and Surgeons and a Master of Public Health and an MBA from Columbia University.
